In contrast, the combination of GVAX + anti-PD-1 + anti-CSF-1R increased the infiltration of PD-1+CD137+CD8+, PD-1+CD137+CD4+, and PD-1+OX40+CD4+ T cells within the tumor. The gene discussed is TNFRSF9; the disease is neoplasm.